ERINN SEYLER: Open Payments
NPI 1346788940 · MIDDLETOWN, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$656 in 29 payments from 10 companies in 2025. Trend: 2023 $395 · 2024 $216 · 2025 $656
Food & beverage: $656
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 9 | $160 |
| LEO Pharma Inc. | 5 | $130 |
| Amgen Inc. | 2 | $104 |
| PFIZER INC. | 4 | $102 |
| LNHC, Inc | 3 | $47 |
| Lilly USA, LLC | 2 | $40 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| ABBVIE INC. | 1 | $18 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $15 |
| Janssen Biotech, Inc. | 1 | $14 |
Products named: ADBRY, NEMLUVIO, OTEZLA, CIBINQO, ZELSUVMI, TALTZ, Rhapsido, DYSPORT.
Industry payments across RI — which companies pay providers there.
